Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2020-04-22 2020-04-06
Drug Identification Number 02418401 02418401
Brand name ANORO ELLIPTA ANORO ELLIPTA
Common or Proper name umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients VILANTEROL UMECLIDINIUM VILANTEROL UMECLIDINIUM
Strength(s) 25MCG 62.5MCG 25MCG 62.5MCG
Dosage form(s) POWDER POWDER
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 30 30
ATC code R03AL R03AL
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-01 2020-04-01
Estimated end date Unknown Unknown
Actual end date 2020-04-21
Shortage status Resolved Actual shortage
Company comments Re-supply is ongoing with inventory allocated to 50% of regular demand. Re-supply is ongoing with inventory allocated to 50% of regular demand.
Health Canada comments